Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Details : CBX129801 is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diabetic Neuropathies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 07, 2012
Lead Product(s) : C-Peptide
Therapeutic Area : Endocrinology
Study Phase : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes
Details : CBX129801 is a drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Diabetes Mellitus, Type 1.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 10, 2011
Lead Product(s) : C-Peptide
Therapeutic Area : Endocrinology
Highest Development Status : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
